Ansari Hourieh, Amini Zahra, Madreseh Elham
Department of Community and Family Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Department of Epidemiology and Biostatistics, School of Health, Tehran University of Medical Sciences, Tehran, Iran.
Int J Reprod Biomed. 2023 Mar 8;21(2):159-166. doi: 10.18502/ijrm.v21i2.12806. eCollection 2023 Feb.
The Coronavirus disease-2019 (COVID-19) pandemic may profoundly impact on maternal and neonatal health worldwide. However, a few studies have investigated this topic.
This study aimed to investigate the impact of the COVID-19 pandemic on maternal and neonatal health.
This retrospective cohort study analyzed collected data from March to May 2020, and the same period in 2019, involving 5711 pregnant women referring to comprehensive healthcare centers in Isfahan province health facilities, Iran. Pregnant women and neonates were followed-up until 40 days after the delivery. Demographic characteristics, pre-pregnancy, antenatal care, and post-pregnancy variables were collected.
A total of 5711 pregnant women were studied, of whom 3477 (61%) were referred in 2019 (before the COVID-19 pandemic as nonexposed) and 2234 (39%) during the COVID-19 pandemic (as exposed group) in 2020. For those living in cities with a population of 20,000, the number of antenatal care were lower about 2% compared to nonexposed group (p = 0.01). The number of mothers with a history of the underlying disease who referred to a comprehensive healthcare center during the COVID-19 pandemic (47%) was lower about 6% compared to nonexposed group (41%) (p 0.001). During the COVID-19 pandemic, the prevalence of hypertension and gestational diabetes mellitus was 5% (n = 109) and 20% (n = 445), which were higher about 2% and 4%, respectively, compared to nonexposed group. The COVID-19 pandemic had no other significant effect on mothers' and neonates' other characteristics than nonexposed group.
The COVID-19 pandemic imposes no significant effect on mothers' and neonates' health compared to nonexposed group.
2019年冠状病毒病(COVID-19)大流行可能会对全球孕产妇和新生儿健康产生深远影响。然而,仅有少数研究对这一主题进行了调查。
本研究旨在调查COVID-19大流行对孕产妇和新生儿健康的影响。
这项回顾性队列研究分析了2020年3月至5月以及2019年同期收集的数据,涉及伊朗伊斯法罕省医疗机构综合保健中心的5711名孕妇。对孕妇和新生儿进行随访,直至分娩后40天。收集了人口统计学特征、孕前、产前护理和产后变量。
共研究了5711名孕妇,其中2019年(COVID-19大流行之前,作为未暴露组)有3477名(61%),2020年COVID-19大流行期间(作为暴露组)有2234名(39%)。对于居住在人口超过2万的城市中的孕妇,其产前检查次数比未暴露组低约2%(p = 0.01)。COVID-19大流行期间转诊至综合保健中心的有基础疾病史的母亲人数(47%)比未暴露组(41%)低约6%(p < 0.001)。在COVID-19大流行期间,高血压和妊娠期糖尿病的患病率分别为5%(n = 109)和20%(n = 445),分别比未暴露组高约2%和4%。与未暴露组相比,COVID-19大流行对母亲和新生儿的其他特征没有其他显著影响。
与未暴露组相比,COVID-19大流行对母亲和新生儿的健康没有显著影响。